28th Apr 2008 07:00
Alliance Pharma PLC28 April 2008 For immediate release 28 April 2008 ALLIANCE PHARMA PLC ("Alliance Pharma" or "the Company") Share Options Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announcesthat on 23 April 2008 it awarded the following share options over ordinaryshares of the Company to certain Directors. Name Position Number of options Exercise price Date of Percentage of awarded per share vesting issued ordinary share capitalTony Booley Sales & Marketing 1,110,000 8.5p 23 April 2011 0.68% DirectorMark Tomlinson Medical Director 1,115,000 8.5p 23 April 2011 0.69%Richard Wright Finance Director 1,113,000 8.5p 23 April 2011 0.69% For further information:Alliance Pharma plc + 44 (0) 1249 466966 John Dawson, Chief ExecutiveRichard Wright, Finance Directorwww.alliancepharma.co.uk Buchanan Communications + 44 (0) 20 7466 5000 Mark Court / Rebecca Skye Dietrich Numis Securities + 44 (0) 20 7260 1000David Poutney / Michael Meade Notes to editors About Alliance Pharma Alliance Pharma, founded in 1996, is an AIM listed speciality pharmaceuticalcompany based in Chippenham, Wiltshire, UK. The company has a strong trackrecord of acquiring the rights to established niche brands and owns, or shares,the rights to 34 branded pharmaceutical products and continues to exploreopportunities to expand the range. Alliance Pharma's products are prescribed in the treatment of a wide range ofconditions and include brands used in the prevention of heart disease, inParkinson's disease, in nutrition, in nasal infections, in the treatment ofdermatological conditions, in childbirth and in the treatment of periodontitis(a serious gum disease). Alliance Pharma's sales are mainly prescriptiondriven. Its products are distributed to hospitals directly and topharmaceutical wholesalers which service both hospital and retail pharmacieswith their prescription requirements. Alliance Pharma joined the AIM market of the London Stock Exchange in December2003 and trades under the symbol APH. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Alliance Pharma